Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01106846 · ClinicalTrials.gov registry record · NA
Analgesic Effect of Ketamine in Patients Undergoing Hysteroscopic Endometrial Thermal Ablation Surgery
A NA study, sponsored by Northwestern University.
- Terminated
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT01106846 is a NA study that was terminated before completion, run by Northwestern University. The registered enrollment target is 22 participants.
The verdict
NCT01106846, a NA study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Hypothesis: The intraoperative administration of ketamine will result in a 30% reduction in opiate requirement following endometrial ablation surgery and the intraoperative administration of ketamine will result in a decreased time to meet discharge criteria in the PACU following endometrial ablation surgery. The research question is "Does intraoperative administration of ketamine result in decreased postoperative opiate requirement and time to discharge from the postanesthesia recovery unit (PACU) following hysteroscopic endometrial ablation".
Interventions
- DRUG Group A: Saline Group
- DRUG Group B: 1% Ketamine group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2010-03 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01106846
The ClinicalTrials.gov registry entry for NCT01106846 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Group A: Saline Group is the first listed.
NCT01106846 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01106846 about?
NCT01106846 is a clinical study titled "Analgesic Effect of Ketamine in Patients Undergoing Hysteroscopic Endometrial Thermal Ablation Surgery". Hypothesis: The intraoperative administration of ketamine will result in a 30% reduction in opiate requirement following endometrial ablation surgery and the intraoperative administration of ketamine will result in a decreased time to meet discharge criteria in the PACU following endometrial ablatio...
What is the current status of trial NCT01106846?
This trial is currently terminated. It is a NA study. The enrollment target is 22 participants. The study started on 2010-03. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01106846?
The interventions under investigation include: Group A: Saline Group (DRUG), Group B: 1% Ketamine group (DRUG).
Who is sponsoring clinical trial NCT01106846?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.